Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer’s disease in mice
    Published on 2023-11-28
    3 years ago
  • Examining the association between posttraumatic stress disorder and disruptions in cortical networks identified using data-driven methods
    Published on 2023-11-27
    3 years ago
  • To lump or to split: cognitive impairment across mood and psychotic disorders
    Published on 2023-11-27
    3 years ago
  • Correction: Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice
    Published on 2023-11-27
    3 years ago
  • Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation
    Published on 2023-11-24
    3 years ago
  • The role of endogenous opioids in mindfulness and sham mindfulness-meditation for the direct alleviation of evoked chronic low back pain: a randomized clinical trial
    Published on 2023-11-19
    3 years ago
  • Should we embrace the term ‘preaddiction’?
    Published on 2023-11-14
    3 years ago
« Previous 1 … 105 106 107 108 109 … 143 Next »
Journal of Psychopharmacology
  • Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
    Published on 2021-01-07
    6 years ago
  • Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging study
    Published on 2021-01-07
    6 years ago
  • Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature
    Published on 2020-12-22
    6 years ago
  • A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
    Published on 2020-12-21
    6 years ago
  • Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial
    Published on 2020-12-14
    6 years ago
  • Dopaminergic neuromodulation has no detectable effect on visual-cue induced haemodynamic response function in the visual cortex: A double-blind, placebo-controlled functional magnetic resonance imaging study
    Published on 2020-12-14
    6 years ago
  • Nitric oxide-mediated defensive and antinociceptive responses organised at the anterior hypothalamus of mice are modulated by glutamatergic inputs from area 24b of the cingulate cortex
    Published on 2020-12-10
    6 years ago
« Previous 1 … 105 106 107 108 109 … 150 Next »
European Neuropsychopharmacology
  • Bidirectional associations between treatment-resistant depression and general medical conditions
    Published on 2021-05-21
    5 years ago
  • MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans
    Published on 2021-05-20
    5 years ago
  • The myth that psychotherapy is more effective than pharmacotherapy in anxiety disorders
    Published on 2021-05-12
    5 years ago
  • White matter microstructure alterations in cortico-striatal networks are associated with parkinsonism in schizophrenia spectrum disorders
    Published on 2021-05-11
    5 years ago
  • Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling
    Published on 2021-05-08
    5 years ago
  • Cognitive reserve in mental disorders
    Published on 2021-05-07
    5 years ago
  • Mind Long COVID: psychiatric sequelae of SARS-CoV-2 infection
    Published on 2021-05-06
    5 years ago
« Previous 1 … 105 106 107 108 109 … 168 Next »

   Pharma Pub